🇺🇸 FDA
Patent

US 10092504

Use of cellular extracts for skin rejuvenation

granted A61KA61K35/60A61K8/676

Quick answer

US patent 10092504 (Use of cellular extracts for skin rejuvenation) held by REGENICS AS expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENICS AS
Grant date
Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K35/60, A61K8/676, A61K8/982, A61K8/987